A Prospective Study on Safety and Effectiveness in Softening, Lightening, and Flattening Raised Scars while Maintaining Skin Moisture and Relieving Discomfort.

ENNOGEN Healthcare International Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•1. Paediatric (Children > 3 months) and adults
•2. Subjects who are healthy or medically fit
•3. Subjects who are willing to participate and able to follow study requirements
•4. Subjects having recent scars and immature scars (6 months to 1 year)
•5. Subjects having scars on the body parts, face, joints, flexures, hairy areas, and large area scars such as those caused by burns (less than 5%) or trauma and surgical/suture scars
•6. Etiology and clinical assessment of the scar indicate that it could benefit from the study treatments
•7. Only to be used on intact skin form of healing

•1. Subjects with chronic skin diseases such as psoriasis, chronic dermatitis, and allergies
•2. Subjects have a history of silicone allergy/sensitivity to rosehip oil, Ximenia oil, sandalwood oil, vitamin E acetate, or ascorbyl tetraisopalmitate
•3. Subjects who are medically unfit
•4. Pregnant subjects or those attempting to become pregnant
•5. Subjects with known immunosuppression or immunosuppressive illness
•6. Subjects with known sensitivity to ingredients in the test treatment products
•7. Subjects having open wounds or sutures not removed
•8. Subjects having no visible scars

发起方

ENNOGEN Healthcare International Limited